ArticleJournal of managed care & specialty pharmacy2016

Real-World Treatment Patterns and Costs for Patients with Renal Cell Carcinoma Initiating Treatment with Sunitinib and Pazopanib.

Elizabeth MacLean et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.